A multispecific antibody confers pan-reactive SARS-CoV-2 neutralization and prevents immune escape.

ABSTRACT: Continued evolution of the SARS-CoV-2 spike poses a challenge to immune interventions. To develop antibodies that protect against evolving SARS-CoV-2 viruses, we combined antibodies that recognize different RBD sites to generate a trivalent antibody that potently neutralized all major variants, including the most recent Omicron lineages. Negative stain electron microscopy suggests that this multispecific achieves synergistic neutralization by engaging different epitopes in specific orientations that facilitate inter-spike binding. These interactions resulted in not only improved potency but also importantly prevented virus escape, a feature not seen with parental antibody cocktails or the most potent clinical antibody. Such multispecific antibodies simplify treatment, maximize coverage, de

SUBMITTER: Misasi J 

PROVIDER: S-EPMC9387125 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature